5. References

  1. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2022. Available at: http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed September 14, 2022.
  2. IMB Micromedex® DRUGDEX® (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu. Accessed September 14, 2022.
  3. Aprepitant capsules, oral suspension (Emend®) package insert. Merck & Co., Inc., May 2022.
  4. Aprepitant oral capsules package insert. Torrent Pharmceuticals Limited. January 2022.
  5. Fosaprepitant dimeglumine for injection (Emend®) package insert. Merck & Co., Inc., May 2022.
  6. Rolapitant tablets, injectable emulsion (Varubi®) package insert. TerSera Therapeutics, LLC., August 2020.
  7. Netupitant/palonosetron capsules (Akynzeo®) package insert. Helsinn Therapeutics (U.S.), Inc., May 2022. 
  8. Hesketh PJ, Kris MG, Basch E, et al. Antiemetics: asco guideline update. Journal of Clinical Onclogy. 2020;38(24):2782-2797.
  9. National Comprehensive Cancer Network. Antiemesis (Version 2.2022). https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf. Accessed September 14, 2022.
  10. Aprepitant emulsion for injection (Cinvanti®) package insert. Heron Therapeutics, Inc., March 2022.